Meyka Pro banner
Quanterix Corporation

Quanterix Corporation (QTRX) Stock Overview

Explore Quanterix Corporation’s financial performance, market position, analyst ratings, and future outlook.

QTRXNASDAQ
HealthcareMedical - Devices
$2.86
$0.07(2.39%)
U.S. Market opens in 2h 58m

Quanterix Corporation (QTRX)

Meyka AI Score

Z

Key Financials

Market Cap134.7M
P/E Ratio-1.10
EPS (TTM)$-1.60
ROE-0.44%
Fundamental Analysis

AI Price Forecasts

1 Month$3.15
3 Months$4.61
1 Year Target$4.10

QTRX Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of Quanterix Corporation (NASDAQ: QTRX) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Quanterix Corporation's NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of QTRX on the NASDAQ shows an RSI of 39.12, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $4.10 for the NASDAQ listing.

Key metrics behind Quanterix Corporation's NASDAQ-traded stock include a P/E ratio of -1.10 and a market capitalization of 134.7M. Combined with our AI analysis, these give both institutional and retail investors a clear view of QTRX on the NASDAQ.

Price Performance (NASDAQ: QTRX)

1-Day Change
-2.39%
5-Day Change
-26.29%
1-Month Change
-26.29%
3-Month Change
-0.69%
6-Month Change
-50.17%
Year-to-Date (YTD) Change
-55.03%
1-Year Change
-40.29%
3-Year Change
-88.73%
5-Year Change
-94.19%
All-Time (Max) Change
-83.63%

Contact Information

617 301 9400
Building 1, Billerica, MA, 01821

Company Facts

4,500 Employees
IPO DateDec 7, 2017
CountryUS
Actively Trading

Frequently Asked Questions